Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ3 | O43525 | 6/20 | 0.71 |
| ▸ | KCNQ2 | O43526 | 6/20 | 0.71 |
| ▸ | KCNE1 | P15382 | 5/20 | 0.71 |
| ▸ | KCNQ1 | P51787 | 5/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.57 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.56 |
| ▸ | CSF1R | P07333 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 2/20 | 0.52 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.51 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL509362 | 0.89 | KCNQ3 (0.71) | KCNQ3KCNQ2KCNE1KCNQ1MEN1 | |
| SCHEMBL775201 | 0.83 | KCNQ3 (0.58) | KCNQ3KCNQ2KCNE1KCNQ1MEN1 | |
| SCHEMBL5214441 | 0.83 | KCNQ3 (1.00) | KCNQ3KCNQ2KCNE1KCNQ1MEN1 | |
| SCHEMBL508480 | 0.80 | KCNQ3 (0.58) | KCNQ3KCNQ2KCNE1KCNQ1MEN1 | |
| SCHEMBL14516641 | 0.80 | KCNQ3 (0.76) | KCNQ3KCNQ2KCNE1KCNQ1MEN1 | |
| SCHEMBL9566835 | 0.79 | P4HTM (0.63) | KCNQ3KCNQ2KCNE1KCNQ1MEN1 | |
| SCHEMBL2696198 | 0.79 | KDM4E (0.74) | KCNQ3KCNQ2KCNE1KCNQ1MEN1 | |
| SCHEMBL27905928 | 0.77 | SMN1; SMN2 (0.58) | MEN1KMT2ANPC1MAPTRAB9A | |
| SCHEMBL9566833 | 0.76 | P4HTM (0.63) | KCNQ3KCNQ2KCNE1KCNQ1KMT2A | |
| SCHEMBL9566797 | 0.75 | P4HTM (0.67) | KCNQ3KCNQ2KCNE1KCNQ1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2528901-B9 | PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2017-01-25 | — | — | EP | disclosed |
| EP-2528901-B1 | PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2015-05-27 | — | — | EP | disclosed |
| US-8791272-B2 | Pyrazole compounds as CRTH2 antagonists | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-07-29 | — | — | US | disclosed |
| EP-2528901-A1 | PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS | Boehringer Ingelheim International GmbH (DE) | 2012-12-05 | — | — | EP | disclosed |
| US-20120028938-A1 | PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-02-02 | — | — | US | disclosed |
| WO-2011092140-A1 | PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028938-A1 | PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS | HRH2, HRH1, HRH3 | KCNQ3 2264/4885KCNQ2 2284/4885KCNE1 2492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.